Cognetivity Neurosciences Ltd. (CGNSF)
USD 0.0
(-94.74%)
USD 0.0
(-94.74%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.29 Million CAD | -0.3% |
| 2022 | 1.29 Million CAD | 312.75% |
| 2021 | 313.65 Thousand CAD | 2.17% |
| 2020 | 307 Thousand CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 1.35 Million CAD | 5.35% |
| 2024 Q3 | 1.36 Million CAD | 0.33% |
| 2024 Q2 | 1.36 Million CAD | 0.29% |
| 2023 FY | 1.29 Million CAD | -0.3% |
| 2023 Q2 | 1.22 Million CAD | -1.02% |
| 2023 Q1 | 1.23 Million CAD | -4.76% |
| 2023 Q4 | 1.29 Million CAD | -7.45% |
| 2023 Q3 | 1.39 Million CAD | 14.27% |
| 2022 Q2 | 894.48 Thousand CAD | 2.54% |
| 2022 Q1 | 872.3 Thousand CAD | 178.11% |
| 2022 Q4 | 1.29 Million CAD | 43.46% |
| 2022 Q3 | 902.39 Thousand CAD | 0.89% |
| 2022 FY | 1.29 Million CAD | 312.75% |
| 2021 Q3 | 358.67 Thousand CAD | 2.58% |
| 2021 Q2 | 349.66 Thousand CAD | 6.79% |
| 2021 Q1 | 327.41 Thousand CAD | 6.65% |
| 2021 Q4 | 313.65 Thousand CAD | -12.55% |
| 2021 FY | 313.65 Thousand CAD | 2.17% |
| 2020 Q4 | 307 Thousand CAD | -50.19% |
| 2020 FY | 307 Thousand CAD | 0.0% |
| 2020 Q3 | 616.39 Thousand CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2018 Q4 | - CAD | -100.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q3 | 637.3 Thousand CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Achiko AG | 2.55 Million USD | 49.521% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 3.6 Million USD | 64.179% |
| Cannabis Sativa, Inc. | 290.22 Thousand USD | -344.734% |
| CompuMed, Inc. | 392.97 Thousand USD | -228.445% |
| CompuGroup Medical SE & Co. KGaA | 846.5 Million USD | 99.848% |
| Cogstate Limited | 672.72 Thousand USD | -91.863% |
| CareView Communications, Inc. | 21.02 Million USD | 93.862% |
| Craneware plc | 35.37 Million USD | 96.351% |
| Caduceus Software Systems Corp. | 2.42 Million USD | 46.831% |
| Certive Solutions Inc. | 5.75 Million USD | 77.577% |
| Drug Free Solution, Inc. | - USD | -Infinity% |
| DATATRAK International, Inc. | 267.41 Thousand USD | -382.666% |
| Strainsforpains, Inc. | 1.93 Million USD | 33.227% |
| Healixa Inc. | 6.59 Million USD | 80.433% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | - USD | -Infinity% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 635.2 Thousand USD | -103.195% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 5062.89 USD | -25393.483% |
| IQ-AI Limited | - USD | -Infinity% |
| Cannabiz Mobile, Inc. | 494.05 Thousand USD | -161.249% |
| Mednow Inc. | 6 Million USD | 78.495% |
| Galileo Life Sciences, Inc. | 20 Thousand USD | -6353.535% |
| MediXall Group, Inc. | 2.82 Million USD | 54.246% |
| Mitesco, Inc. | 1.76 Million USD | 26.943% |
| MobileSmith, Inc. | 5.43 Million USD | 76.239% |
| NantHealth, Inc. | 267.4 Million USD | 99.517% |
| Net Medical Xpress Solutions, Inc. | 949 Thousand USD | -36.007% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 8.53 Million USD | 84.886% |
| Patient Access Solutions, Inc. | 925.37 Thousand USD | -39.48% |
| Pharma-Bio Serv, Inc. | 346.5 Thousand USD | -272.489% |
| PPJ Healthcare Enterprises, Inc. | 2.59 Million USD | 50.224% |
| Medical Cannabis Payment Solutions, Inc. | 857.76 Thousand USD | -50.473% |
| Renalytix Plc | 8.53 Million USD | 84.877% |
| Revium Recovery Inc. | 1000.00 USD | -128970.7% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 27.55 Thousand USD | -4584.962% |
| Vaso Corporation | 2.06 Million USD | 37.344% |
| Vynleads, Inc. | 527.8 Thousand USD | -144.541% |